ArticleEClinicalMedicine2025

Modelling the potential financial impacts of expanding access to immune checkpoint inhibitors as monotherapy for treating advanced non-small cell lung cancer.

Kiu Tay-Teo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.